Alithea Genomics
PrivateLast Round
Seed
Mar 4, 2026
Total Funding Raised
$13.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alithea Genomics is a biotechnology company that develops and commercializes massively multiplexed library preparation solutions for RNA sequencing, designed to accelerate drug development and biomarker discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alithea Genomics Comparables
Compare Alithea Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lexogen | 86% | |
| BioSpyder Technologies, Inc. | 85% | |
| BioClavis | 78% | |
Alithea Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 4, 2026 | ||||
| Debt | Sep 24, 2024 | ||||
| Seed | Mar 14, 2024 | ||||
| Debt | Mar 21, 2023 | ||||
| Seed | May 24, 2022 | ||||
Grant | Apr 28, 2021 |
Key People
Founding team and executive leadership
Alithea Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TechU Ventures | Seed |
| Foundation for Technological Innovation | Debt |
| Novalis Biotech | Seed |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
$9M round with participation from Novalis Biotech.
- Sep 24, 2024
Secured debt financing from Swiss Technology Fund.
Alithea Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alithea Genomics's valuation, stock price, and market status.